English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Children with acute lymphoblastic leukemia (ALL) receiving chemotherapy are at high risk for developing hepatitis B infection. Protective effect of hepatitis B vaccination in children with ALL in Indonesia has not been investigated yet. The aim of study was to determine the proportion difference of anti-HBs seroprotection between children with ALL and without malignancy post hepatitis B vaccination. We had conducted a case-control study from January to February 2012 at Dr. Sardjito General Hospital, Yogyakarta. We ascertained 1-15 years old children with ALL receiving chemotherapy and without malignancy who had hepatitis B vaccination. Sixty seven children were included in this study. Anti-HBs seroprotection level was measured using an enzyme-linked immunosorbent assay (ELISA). The results were analyzed using Chi-square test. Twenty one children (65.6%) with ALL and 13 children (37.1%) without malignancy showed anti-HBs seroprotection. The difference was statistically significant with p-value of 0.020 (prevalence ratio [PR]=0.3; 95% CI=0.11-0.84). Both groups showed no significantly difference of anti-HBs seroprotection according to either female gender, risk classification, or phase of chemotherapy with p-value of 0.38 (PR =4; 95% CI=1.05-15.2), 0.248 (PR =3.37; 95% CI=0.58-19.6) or 0.214, respectively. In conclusion, the proportion of anti-HBs seroprotection in children with ALL is higher than those without malignancy.

Anti-hepatitis B surface (anti-HBs) seroprotection in children with acute lymphoblastic leukemia post hepatitis B vaccination in Indonesia